These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 36075472)

  • 21. Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications.
    Yang Q; Xu J; Gu J; Shi H; Zhang J; Zhang J; Chen ZS; Fang X; Zhu T; Zhang X
    Adv Sci (Weinh); 2022 Dec; 9(34):e2201609. PubMed ID: 36253096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading.
    Sutaria DS; Badawi M; Phelps MA; Schmittgen TD
    Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer.
    Kugeratski FG; McAndrews KM; Kalluri R
    Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33411885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
    Wu M; Wang M; Jia H; Wu P
    Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxic regulation of extracellular vesicles: Implications for cancer therapy.
    Yoo S; Choi S; Kim I; Kim IS
    J Control Release; 2023 Nov; 363():201-220. PubMed ID: 37739015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery.
    Ilahibaks NF; Ardisasmita AI; Xie S; Gunnarsson A; Brealey J; Vader P; de Jong OG; de Jager S; Dekker N; Peacock B; Schiffelers RM; Sluijter JPG; Lei Z
    J Control Release; 2023 Mar; 355():579-592. PubMed ID: 36746337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in therapeutic applications of extracellular vesicles.
    Wiklander OPB; Brennan MÁ; Lötvall J; Breakefield XO; El Andaloussi S
    Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoregulatory Roles of Extracellular Vesicles and Associated Therapeutic Applications in Lung Cancer.
    Yin Z; Fan J; Xu J; Wu F; Li Y; Zhou M; Liao T; Duan L; Wang S; Geng W; Jin Y
    Front Immunol; 2020; 11():2024. PubMed ID: 32983146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface-Engineered Extracellular Vesicles in Cancer Immunotherapy.
    Johnson V; Vasu S; Kumar US; Kumar M
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications.
    Wang L; Wang D; Ye Z; Xu J
    Adv Sci (Weinh); 2023 Jun; 10(17):e2300552. PubMed ID: 37080941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects.
    Hang Y; Huang J; Ding M; Shen Y; Zhou Y; Cai W
    Int Immunopharmacol; 2024 Oct; 140():112820. PubMed ID: 39096874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered Extracellular Vesicles to Enhance Antigen Presentation for Boosting Light-Driven Tumor Immunotherapy.
    Li X; He S; Luo B; Li P; Chen X; Wu M; Song C; Liu C; Yang T; Zhang X; Yang X; Hu J
    Small; 2023 Dec; 19(49):e2303541. PubMed ID: 37608451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular Vesicles: A New Star for Gene Drug Delivery.
    Sun M; Zhang H; Liu J; Chen J; Cui Y; Wang S; Zhang X; Yang Z
    Int J Nanomedicine; 2024; 19():2241-2264. PubMed ID: 38465204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered Extracellular Vesicles: Emerging Therapeutic Strategies for Translational Applications.
    Ziegler JN; Tian C
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.
    Yang P; Peng Y; Feng Y; Xu Z; Feng P; Cao J; Chen Y; Chen X; Cao X; Yang Y; Jie J
    Front Immunol; 2021; 12():771551. PubMed ID: 34956197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.